PREZCOBIX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Products Lp. The primary component is Darunavir Ethanolate; Cobicistat.
Product ID | 59676-575_3b08bc19-c69e-4e44-9f65-edd0851c94a1 |
NDC | 59676-575 |
Product Type | Human Prescription Drug |
Proprietary Name | PREZCOBIX |
Generic Name | Darunavir Ethanolate And Cobicistat |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2015-01-31 |
Marketing Category | NDA / NDA |
Application Number | NDA205395 |
Labeler Name | Janssen Products LP |
Substance Name | DARUNAVIR ETHANOLATE; COBICISTAT |
Active Ingredient Strength | 800 mg/1; mg/1 |
Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-01-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205395 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-31 |
Ingredient | Strength |
---|---|
DARUNAVIR ETHANOLATE | 800 mg/1 |
SPL SET ID: | 9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50090-1723 | PREZCOBIX | DARUNAVIR ETHANOLATE and COBICISTAT |
59676-575 | PREZCOBIX | DARUNAVIR ETHANOLATE and COBICISTAT |
70518-0714 | PREZCOBIX | DARUNAVIR ETHANOLATE and COBICISTAT |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PREZCOBIX 85845782 4720657 Live/Registered |
JANSSEN SCIENCES IRELAND UNLIMITED COMPANY 2013-02-11 |